Stocks
BridgeBio (BBIO) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -279.8 | -465.7 | -533.8 | -397.4 | -565.5 | -350.3 | ||
| Changes by years, y/y, % | +53% | +66% | +15% | -26% | +42% | +25.3% | |||
BridgeBio. EBITDA US GAAP, bln rub
BridgeBio. EBITDA US GAAP, changes, %
BridgeBio. EBITDA US GAAP, sum by quarters, bln rub
BridgeBio (BBIO) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -157.5 | -148.5 | -11.1 | -51.0 | -139.7 | -350.3 | |
| Changes by years, y/y, % | +39% | +32% | -91% | -63% | -11% | |||
| Changes by quarters, q/q, % | +14% | -6% | -93% | +360% | +174% | |||
